Stephens Cuts Tenet Healthcare (NYSE:THC) Price Target to $260.00

Key Points

• Stephens cut its price target on Tenet to $260 (from $275) but kept an "overweight" rating, a level that implies roughly a 41.9% upside from the stock's prior close.
• Tenet beat Q results with $4.82 EPS (vs. $4.21 est.) and set FY2026 guidance of 16.38–18.68 EPS, while sell‑side forecasts average about 17.42 EPS for the year.
• Analyst sentiment remains strongly positive overall — 19 Buy ratings vs. 3 Holds and a consensus target of $242.89 — while the stock trades around $183.23, reflecting notable analyst-implied upside.

Tenet Healthcare (NYSE:THC - Get Free Report) had its price objective reduced by equities researchers at Stephens from $275.00 to $260.00 in a research note issued on Monday, MarketBeat reports. The brokerage presently has an "overweight" rating on the stock. Stephens' price target indicates a potential upside of 41.90% from the stock's previous close.

A number of other research analysts have also recently weighed in on THC. Mizuho raised their price target on Tenet Healthcare from $235.00 to $265.00 and gave the company an "outperform" rating in a research report on Thursday, March 12th. Barclays raised their price target on Tenet Healthcare from $240.00 to $257.00 and gave the stock an "overweight" rating in a research note on Friday, February 13th. Truist Financial raised their price target on Tenet Healthcare from $240.00 to $270.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. Weiss Ratings reissued a "buy (b-)" rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Finally, TD Cowen reaffirmed a "buy" rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $242.89.

Tenet Healthcare Trading Down 0.0%

NYSE:THC opened at $183.23 on Monday. The stock has a fifty day moving average price of $207.31 and a two-hundred day moving average price of $204.33. The stock has a market capitalization of $16.05 billion, a price-to-earnings ratio of 9.53, a PEG ratio of 1.37 and a beta of 1.30. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. Tenet Healthcare has a 1 year low of $145.27 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to analysts' expectations of $5.39 billion. During the same quarter in the prior year, the business posted $4.36 earnings per share. Tenet Healthcare's revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare will post 17.42 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 6,500 shares of the firm's stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the firm's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 46,517 shares of company stock worth $10,943,111. 0.81% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds have recently modified their holdings of the stock. WCM Investment Management LLC increased its holdings in Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company's stock worth $102,657,000 after purchasing an additional 362,083 shares during the last quarter. AlphaQuest LLC increased its holdings in Tenet Healthcare by 238.3% during the 3rd quarter. AlphaQuest LLC now owns 5,965 shares of the company's stock worth $1,211,000 after purchasing an additional 4,202 shares during the last quarter. Winnow Wealth LLC purchased a new stake in Tenet Healthcare during the 3rd quarter worth approximately $1,129,000. Savant Capital LLC increased its holdings in Tenet Healthcare by 27.5% during the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company's stock worth $3,430,000 after purchasing an additional 3,647 shares during the last quarter. Finally, Caption Management LLC purchased a new stake in Tenet Healthcare during the 3rd quarter worth approximately $5,650,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.